Prostate Cancer

Cancer Diagnoses Increase at Age 65, Decrease Immediately Afterward

By

Colby Stong

Publish Date May 5, 2021

The largest increase in cancer diagnosis at age 65 years was in stage I for all breast cancer, colon cancer, prostate cancer, and lung cancer.

Black and White Men Had Similar Outcomes After Radical Prostatectomy

By

Leah Lawrence

Publish Date April 29, 2021

Black men were less likely to receive androgen deprivation therapy and had lower use of secondary treatment with radiotherapy.

Nonmetastatic CRPC Treatments Compared for Efficacy and Safety

By

Natasha Persaud

Publish Date April 26, 2021

Investigators compared the efficacy, safety, and costs of abiraterone, darolutamide, enzalutamide, and apalutamide in treating nmCRPC.

PLND Extent During Prostate Surgery Linked With Perioperative Complications

By

Natasha Persaud

Publish Date April 22, 2021

The technical challenges and potential complications of extended PLND warrant careful consideration, according to investigators.

Study Reveals Clinical Heterogeneity of Favorable Intermediate-Risk PCa

By

Jody A. Charnow

Publish Date April 13, 2021

Patients’ risk of pathologic upgrading may depend on their intermediate-risk factor (Gleason score 3+4, PSA level of 10-20 ng/mL, and cT2b-c disease).

Prostate Cancer Resources

Clinical Trials

Drug Monographs

Fact Sheets